INM
Price
$3.00
Change
+$0.04 (+1.36%)
Updated
Apr 24, 04:51 PM (EDT)
Capitalization
3.56M
PYPD
Price
$2.67
Change
-$0.09 (-3.27%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
27.62M
13 days until earnings call
Ad is loading...

INM vs PYPD

Header iconINM vs PYPD Comparison
Open Charts INM vs PYPDBanner chart's image
InMed Pharmaceuticals
Price$3.00
Change+$0.04 (+1.36%)
Volume$100
Capitalization3.56M
PolyPid
Price$2.67
Change-$0.09 (-3.27%)
Volume$200
Capitalization27.62M
INM vs PYPD Comparison Chart
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. PYPD commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Buy and PYPD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (INM: $2.95 vs. PYPD: $2.75)
Brand notoriety: INM and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 29% vs. PYPD: 50%
Market capitalization -- INM: $3.56M vs. PYPD: $27.62M
INM [@Biotechnology] is valued at $3.56M. PYPD’s [@Biotechnology] market capitalization is $27.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 7 TA indicator(s) are bullish while PYPD’s TA Score has 5 bullish TA indicator(s).

  • INM’s TA Score: 7 bullish, 3 bearish.
  • PYPD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INM is a better buy in the short-term than PYPD.

Price Growth

INM (@Biotechnology) experienced а +10.52% price change this week, while PYPD (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

INM is expected to report earnings on Nov 14, 2024.

PYPD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($27.6M) has a higher market cap than INM($3.56M). PYPD YTD gains are higher at: -9.539 vs. INM (-35.732). INM has higher annual earnings (EBITDA): -7.44M vs. PYPD (-26.41M). PYPD has more cash in the bank: 15.6M vs. INM (3.42M). INM has less debt than PYPD: INM (949K) vs PYPD (9.62M). INM has higher revenues than PYPD: INM (4.83M) vs PYPD (0).
INMPYPDINM / PYPD
Capitalization3.56M27.6M13%
EBITDA-7.44M-26.41M28%
Gain YTD-35.732-9.539375%
P/E Ratio0.01N/A-
Revenue4.83M0-
Total Cash3.42M15.6M22%
Total Debt949K9.62M10%
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMPYPD
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRRX8.41N/A
N/A
Fidelity Strategic Real Return
PFSZX22.33N/A
N/A
PGIM Jennison Financial Services Z
EIVAX12.91N/A
N/A
Allspring Special Large Cap Value A
PNOYX120.69N/A
N/A
Putnam Sustainable Leaders Y
AFPIX4.14N/A
N/A
DSS AmericaFirst Income I

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
+0.68%
TTNP - INM
49%
Loosely correlated
+1.37%
EYEN - INM
39%
Loosely correlated
+0.01%
OMER - INM
36%
Loosely correlated
-2.52%
VTYX - INM
31%
Poorly correlated
-1.69%
PULM - INM
30%
Poorly correlated
+0.00%
More